Back to search

Belgium· BE-AMP-SAM072107-00

Pre-Par 50 mg/5 ml

A ritodrine product containing ritodrine hydrochloride, registered in Belgium by Eumedica. The same ATC class is registered in 3 of our 19 countries.

ATC G02CA01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedPre-Par 50 mg/5 mlATCG02CA01REGISTER NO.BE-AMP-SAM072107-00PACKS LISTED3CHECKEDSeptember 26, 2026

Where it is registered

Ritodrine is registered in 3 of 19 countries.

Countries holding a registration under ATC G02CA01 (ritodrine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 2 of them publish a price we can compare per daily dose

Ritodrine · ATC G02CA01

3 / 19 countries

  • Belgiumprice
  • Finlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ritodrine Hydrochloride
Manufacturer
Eumedica
Country
Belgium (BE)
ATC code
G02CA01
ATC class
Ritodrine
Defined daily dose
40 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

  • be_apb
    0071217
  • be_apb
    0715532
  • be_apb
    1373059

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

239 interactions on record for ritodrine.

Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ritodrine · interactions on record

239 records

  • 30 severe
  • 185 moderate
  • 24 minor

Most severe, free to view

  • DolasetronA04AA04severe
  • PasireotideH01CB05severe
  • NilotinibL01EA03severe
  • OsimertinibL01EB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ritodrine in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ritodrine products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Spain · Pre-Par

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/687934f8-7cba-452c-a62b-45be13cbc45e
GET /v1/drugs/687934f8-7cba-452c-a62b-45be13cbc45e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Pre-Par 50 mg/5 ml",
  "name_fr": "Pre-Par 50 mg/5 ml",
  "name_nl": "Pre-Par 50 mg/5 ml",
  "amp_code": "SAM072107-00",
  "strengths": [
    "5.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Ritodrine Hydrochloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ritodrine",
  "authorisation_numbers": [
    "BE072107"
  ]
}

See everything about ritodrine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.